Vertex and Verve Therapeutics Establish Collaboration to Discover and Develop an In Vivo Gene Editing Program for Liver Disease

Verve to Receive $25 Million Upfront Payment and $35 Million Equity Investment, as Well as Potential Milestones and Roy...

Related Keywords

Boston ,Massachusetts ,United States ,Australia ,Cambridge ,Cambridgeshire ,United Kingdom ,London ,City Of ,America ,Jen Robinson ,Miroslava Minkova ,Heather Nichols ,Ashlea Kosikowski ,David Altshuler ,Sekar Kathiresan ,Manisha Pai ,Global Research ,Instagram ,Linkedin ,Twitter ,Nasdaq ,Vertex Pharmaceuticals Incorporated ,Verve Therapeutics Inc ,Exchange Commission ,Youtube ,Facebook ,Vertex Pharmaceuticals Incorporated Nasdaq ,Upfront Payment ,Equity Investment ,Potential Milestones ,Pharmaceuticals Incorporated ,Verve Therapeutics ,Chief Executive Officer ,Executive Vice President ,Chief Scientific Officer ,Innovation District ,North America ,Top Employers ,Private Securities Litigation Reform Act ,Investor Contact ,Media Contact ,新浪香港 ,新浪 ,新浪網 ,香港 ,Sina ,Sina Com Hk ,Hong Kong ,